Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05930132
Other study ID # MKSU50-9-22
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2018
Est. completion date April 30, 2020

Study information

Verified date July 2023
Source Kafrelsheikh University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study aimed to compare the applicability of the classic lateral lamellectomy versus the submucosal conchoplasty techniques in managing the concha bullosa during and after ESS.


Description:

The study included fifty-six patients with bilateral concha bullosa who were undergoing primary ESS for refractory chronic sinusitis. They were divided into two equal groups randomly. One group had the submucosal conchoplasty technique, and the other group had the lateral lamellectomy technique. The study compared the intraoperative findings including the time required for each technique and the amount of intraoperative bleeding. Furthermore, it compared the postoperative endoscopic outcome of the middle meatus and middle turbinate stability using the LKES and the POSE score. Also, the postoperative olfaction outcome was assessed.


Recruitment information / eligibility

Status Completed
Enrollment 56
Est. completion date April 30, 2020
Est. primary completion date April 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patients above 18 years - patients diagnosed with chronic sinusitis based on the 2012 European Position Paper on Rhino-sinusitis and Nasal Polyps's criteria (EPOS 2012) - patients presented by bilateral concha bullosa Exclusion Criteria: - patients below 18 years - smokers - patients with nasal polyps - patients with primary ciliary dyskinesia - patients with nasal masses - revision cases

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
submucosal conchoplasty
Regarding the submucosal conchoplasty technique, the concha was locally infiltrated with adrenaline with a concentration of 1:200,000. The mucosa was incised by blade 15 starting from the axilla posteriorly up to the attachment with the basal lamella. The mucosa covering the lateral lamella was dissected using the freer dissector. The lateral lamella was removed using a through cut forceps then the mucosa was repositioned. The bony skeleton of the medial lamella was preserved
classic lateral lamellectomy
Regarding the lateral lamellectomy technique, the concha was locally infiltrated with adrenaline with a concentration of 1:200,000; the sickle knife was used to open the concha then the scissor was used to remove the lateral lamella with its covering mucosa in one block. No middle meatus packing was applied. Systemic antibiotics and steroids (0.5 mg / kg prednisolone) were given for two weeks after the surgery. The patients were instructed to use local nasal irrigations (2 ml of budesonide 0.5 mg / ml mixed with 250 ml of normal saline) two times daily for a month postoperatively. Patients were followed up at the end of each month throughout the six months follow-up period.

Locations

Country Name City State
Egypt Kafrelsheikh university Sakha Kafrelsheikh

Sponsors (1)

Lead Sponsor Collaborator
Kafrelsheikh University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary the clinical symptoms before and after the surgery through the Sino-nasal outcome test 22. (SNOT 22) The study assessed the clinical symptoms before and after the surgery through the Sino-nasal outcome test 22. (SNOT 22) Patients were followed up at the end of six month after surgery ( change from baseline )
Secondary the time of the technique in minutes during the operation
Secondary the amount of bleeding in cubic centimeters during the operation
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04078659 - Propofol and Magnesium Sulfate Intravenous Infusion During Endoscopic Sinus Surgery N/A
Not yet recruiting NCT03417206 - PRD-guided Analgesia During FESS for Intraoperative Blood Loss N/A
Recruiting NCT03417180 - SPI-guided Analgesia During FESS for Intraoperative Blood Loss N/A
Completed NCT02692794 - Large Scale Cerebral Oximetry During Sinus Endoscopy N/A
Not yet recruiting NCT05829148 - The Effect of Dexmedetomidine, Melatonin and Pregabalin Early Phase 1
Completed NCT03229551 - Xylitol for Chronic Sinusitis Phase 2/Phase 3
Active, not recruiting NCT04356196 - Comparative Study Between the Efficacy of Verapamil and Bisoprolol on Reduction of Bleeding During Endoscopic Sinus Surgery Under General Anaesthesia. Early Phase 1
Completed NCT03228914 - Comparing Blood Loss and Visualization After the Preoperative Use of Topical 0.05% Oxymetazoline Versus 1:1000 Epinephrine Prior to Endoscopic Sinus Surgery Phase 4
Completed NCT03389763 - SPI-guided vs PRD-guided Analgesia During FESS for Intraoperative Blood Loss N/A
Completed NCT02182492 - Efficacy of Macrolide and Glucocorticoid in the Treatment of Chronic Rhinosinusitis After Endoscopic Sinus Surgery N/A
Recruiting NCT04852562 - The Effect of Modified Radical Endoscopic Sinus Surgery on Eosinopilic Chronic Rhinosinusitus With Nasal Polyps N/A
Recruiting NCT05145543 - Effect of Topically Administered Levobupivacaine- Fentanyl Versus Levobupivacaine- Dexamethasone Combination in the Control of Pain After Endoscopic Sinus Surgery Phase 2/Phase 3
Completed NCT02748070 - Perioperative Oral Steroids for Chronic Rhinosinusitis Without Polyps (CRSsNP) N/A
Completed NCT01564355 - Postoperative Systemic Corticosteroids When Utilizing a Steroid-Eluting Spacer Following Endoscopic Sinus Surgery N/A